Overview
Financials
Revenue history (in m)
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Industry
Bank accounts
Registered as a VAT taxpayer on 2015-12-30. Active
14 1160 2202 0000 0003 7061 0295
24 1090 1098 0000 0001 3481 8182- 68 1160 2202 0000 0003 7061 0002
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Jun 20, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $2,094$2,094 | Prezes Zakładu Ubezpieczeń Społecznych | |
| May 30, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $1,685$1,685 | Prezes Zakładu Ubezpieczeń Społecznych | |
| May 30, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $1,645$1,645 | Prezes Zakładu Ubezpieczeń Społecznych |
Tenders
No recorded participation in tenders.
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
 BDO | BDO register entry | Active |
Authorized Representatives
Manner of representation
In the case of a one-person management board, the sole member of the management board is authorised to independently make declarations of will on behalf of the company and to represent it. In the case of a multi-member management board, two members of the management board jointly or one member of the management board jointly with a commercial proxy are authorised to make declarations on behalf of the company and represent it.
Supervisory board
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Value Pharmacy B.v. | 158,312 | $2,138,195.57 | 100% |
Beneficial owners
| Person | Rights | |
|---|---|---|
Roman Piotr Pałac (46)  | Natural person holding a senior management position (AML Act art. 2(2)(1)(a) indent 5). | |
Grzegorz Bolesław Postolski (45) | Natural person holding a senior management position (AML Act art. 2(2)(1)(a) indent 5). | |
Grzegorz Sadowski (51) | Natural person holding a senior management position (AML Act art. 2(2)(1)(a) indent 5). | |
Sebastian Trzmiel (45) | Natural person holding a senior management position (AML Act art. 2(2)(1)(a) indent 5). |
Subsidiaries
| Name | Share value | Stake | ||
|---|---|---|---|---|
Gemini Hüttersp. z o.o. | 27,012.43 USD | 100% | ||
AGIPsp. z o.o. | 1,350.62 USD | 100% | ||
Centrum Dystrybucji Lekówsp. z o.o. | 1,350.62 USD | 100% |
Capital group
| Name | Ownership |
|---|---|
| 100% | |
Gemini Hutter Sp. z o.o | 100% |
podziału zysku Gemini Drugstore Sp. z o.o | 0% |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| EurotelS.A. | $118,216,725.26 | eurotel.pl | ||
| Gemini Polskasp. z o.o. | $82,468,509.28 | gemini.pl | ||
| Reino CapitalS.A. | $35,341,436.97 | reinocapital.pl | ||
| ING Investment Holding (Polska)S.A. | $23,155,668.85 | ing-ihp.pl | ||
| Lokum DeweloperS.A. | $13,439,477.65 | lokumdeweloper.pl | ||
| Grupa NdiS.A. | $8,502,938.88 | ndi.pl | ||
| Eurowind HoldingS.A. | $78,622.61 | eurowind.pl | ||
| Real Estate Invest 5S.A. | $0.00 | realestateinvest5.pl | ||
| Isarkosp. z o.o. | $0.00 | investsarko.pl | ||
| Horeca Holdingsp. z o.o. | — | iglotex.pl |
Change history
| Date | Event | |
|---|---|---|
| 2023-06-07 | Address change (Al. Grunwaldzka 411, 80-309, Gdańsk → Aleja Grunwaldzka 411, 80-309, Gdańsk) | |
| 2019-10-15 | Share capital change (2,960,000.00 PLN → 7,915,600.00 PLN) | |
| 2019-01-28 | PKD change (Removed: 70.21.Z, 71.20.B; Added: 49.41.Z, 52.24.C, 53.20.Z) | |
| 2018-06-28 | Share capital change (1,161,000.00 PLN → 2,960,000.00 PLN) | |
| 2018-02-13 | Address change (Al. Aleje Jerozolimskie 56c, 00-803, Warszawa → Al. Grunwaldzka 411, 80-309, Gdańsk) |
FAQ
Last updated: 2026-07-04